Menu

氨己烯酸片(喜保宁)一盒多少片

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

As early as August 2009, it was approved by the US FDA for marketing. It is suitable for monotherapy in children aged 1 month to 2 years old. Its potential benefits for infantile spasms outweigh the potential risk of vision loss, and it can be used as an auxiliary (additional) treatment (CPS) for adult patients with refractory complex partial epilepsy. On January 16, 2019, the FDA approved the launch of a generic version of vigabatrin.

The main component of vigabatrin tablets (vigabatrin) is vigabatrin (vigabatrin). Its mechanism of action is to irreversibly inhibit GABA aminotransferase (GABA-T) and increase the concentration of GABA in the brain to play its role. In the past two years, more and more children with TSC have effectively controlled epilepsy by using vigabatrin tablets (Vigabatrin). Western countries even use vigabatrin tablets (Vigabatrin) to prevent brain abnormalities in children with TSC who have not yet developed the disease. It can be seen that the effect is quite significant.

How many vigabatrin tablets (Vigabatrin) are there in a box? The specifications of vigabatrin tablets produced by Sanofi in France are 500mg*100 tablets.

Dosage and usage of vigabatrin tablets (vigabatrin): The use of vigabatrin tablets (vigabatrin) should be done under the guidance of an epilepsy expert or a child neurologist. Reactions after taking the medication should be reported to the doctor promptly.

It is an oral medicine that can be taken once or twice a day, before or after meals. It is advisable to drink half a glass of water when taking medicine. If your epilepsy does not improve after taking it for a sufficient period of time, you should stop taking vigabatrin tablets. At this time, vigabatrin should be gradually stopped under the supervision of a doctor. Children younger than 6 years old are prone to choking when taking tablets, so please pay attention to this.

Recommended hot articles: /newsDetail/84518.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。